Organisation paid for research Program year 2022 Source: CMS Open Payments

Ocala Eye PA

Neither a doctor nor a teaching hospital

Research payments

$31,225

16 payments

Through program year 2022, Ocala Eye PA is reported as receiving $31,225 in research payments, across 16 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$198	1
2021	Research	$2,758	3
2020	Research	$5,848	3
2019	Research	$22,422	9

Breakdown

Who paid Research payments · program years 2019–2022

Allergan Inc. $16,175 8 payments
Ivantis, Inc $15,050 8 payments

Studies the money was for Research payments · program years 2019–2022

A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients with Open-Angle Glaucoma or Ocular Hypertension $15,602 7 payments
Safety & Effectiveness Study of the Hydrus Microstent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery (HORIZON) $6,975 3 payments
Hydrus Microstent for Refractory Open-Angle Glaucoma: a Prospective| Multicenter Clinical Trial (SUMMIT) $5,890 3 payments
CS Hydrus IV $1,750 1 payment
A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients with Open-Angle Glaucoma or Ocular Hypertension $573 1 payment
CS Summit $435 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.